As a transcript factor, EBF1 over-expression increases DNA damage by directly targeting RAD51 in leukemia (20), while EBF1 knockdown promotes cell proliferation and migration by increasing CD133, Oct3/4, and TFF1 expression in CCA (25). This evidence concerns the gene PROM1 and cholangiocarcinoma.